This document provides recommendations for the screening, diagnosis and treatment of FH in pediatric and adult patients developed by the National Lipid Association Expert Panel on Familial Hypercholesterolemia. READ MORE »
Anne Goldberg, Paul Hopkins, Peter Toth, et al (Mar 2011)

This review focuses on the screening and diagnosis of heterozygous familial hypercholesterolemia (HeFH), including appropriate cardiovascular risk assessment with current treatment recommendations. READ MORE »
Sanford Carimi (Winter 2013)

Several therapies are available, or in development, for the treatment of FH. In this article, we will briefly describe LDL-apheresis, PCSK9 inhibitors, mipomersen, and lomitapide, largely reflecting a summary of ... READ MORE »
Kevin Maki, Mary Dicklin (Winter 2013)

FH is a co-dominantly inherited disorder of lipid metabolism characterized by a defective allele (or alleles) in the gene coding for LDLR. READ MORE »
Kaye-Eileen Willard (Winter 2013)

Options for treatment of severe heterozygous and homozygous familial hypercholesterolemia prior to the statin era were limited by significant side effects and morbidity. The advent of both the statins and technology for ... READ MORE »
Linda Hemphill (Aug 2010)